Key result
Measurements of B-type natriuretic peptide are accurate in diagnosing coexisting left heart failure in COPD patients, though diagnostic thresholds are elevated compared to those without COPD.
Why the study?
Does measurement of BNP or NT-proBNP accurately diagnose left heart dysfunction in patients with chronic obstructive pulmonary disease?
Population
Chronic obstructive pulmonary disease patients, either in stable condition, during acute exacerbation, or…
Design
Review
Authors
Loading...
Supports higher BNP thresholds for left heart failure diagnosis in COPD; leaves open prospective validation before routine adoption.
Does measurement of BNP or NT-proBNP accurately diagnose left heart dysfunction in patients with chronic obstructive pulmonary disease?
BNP and NT-proBNP are accurate diagnostic markers for left heart failure in COPD patients, though they require higher diagnostic thresholds than in the general population.
Abroug et al. (2008) conducted a review in Chronic obstructive pulmonary disease and acute heart failure. B-type natriuretic peptide (BNP) measurement was evaluated on Diagnosis of left heart dysfunction. Measurements of B-type natriuretic peptide are accurate in diagnosing coexisting left heart failure in COPD patients, though diagnostic thresholds are elevated compared to those without COPD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: